In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantationPanagiotis Kottaridis, Stephen Mackinnon, Stephen Schey et al.|Blood|2000Cited by 502
ELIMINATION OF GRAFT-VERSUS-HOST DISEASE BY IN-VITRO DEPLETION OF ALLOREACTIVE LYMPHOCYTES WITH A MONOCLONAL RAT ANTI-HUMAN LYMPHOCYTE ANTIBODY (CAMPATH-1)Herman Waldmann, S Slavin, G Hale et al.|The Lancet|1984Cited by 424
Infectious tolerance via the consumption of essential amino acids and mTOR signalingStephen Cobbold, Herman Waldmann|Proceedings of the National Academy of Sciences|2009Cited by 324
Foxp3 drives oxidative phosphorylation and protection from lipotoxicityDuncan Howie, Herman Waldmann|JCI Insight|2017Cited by 196
T‐cell‐depleted allogeneic bone marrow transplantation for acute leukaemia using Campath‐1 antibodies and post‐transplant administration of donor's peripheral blood lymphocytes for prevention of relapseE Naparstek, Shimon Slavin, Reuven Or et al.|British Journal of Haematology|1995Cited by 157